The U.S. Food and Drug Administration recently approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD).
Willamette Valley Fruit Co, Salem, Ore., is voluntarily recalling select packages of frozen fruit containing strawberries grown in Mexico due to the potential for Hepatitis A contamination.
This month, the U.S. Food and Drug Administration announced the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease.
U.S. lawmakers on Tuesday debated if enough has changed to prevent a repeat of the infant formula shortage, more than a year after a nationwide crisis began.
